World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
21229
World Ranking
2569
National Ranking
1035

Peter Halfmann publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Peter Halfmann sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 203 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Peter Halfmann D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter Halfmann sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Peter Halfmann is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily focuses on infectious diseases within the broader field of medicine, with significant contributions in epidemiology, molecular biology, animal science and zoology, as well as immunology. Their extensive body of work highlights a concentrated investigation into viral infections, particularly SARS-CoV-2 and COVID-19.

The main topics of Peter Halfmann's research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Viral gastroenteritis research and epidemiology
  • Animal Virus Infections Studies
  • Influenza Virus Research Studies
  • Viral Infections and Outbreaks Research

They have published extensively in high-impact journals, with frequent contributions to venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • SSRN Electronic Journal
  • Nature Communications
  • New England Journal of Medicine

Peter Halfmann's recent notable papers include:

  • "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift," 2021, Nature
  • "Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development," 2020, Proceedings of the National Academy of Sciences
  • "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo," 2020, Science
  • "An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies," 2022, Nature Medicine
  • "SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters," 2022, Nature

Collaboration plays an important role in their research activities. Their frequent co-authors include:

  • Yoshihiro Kawaoka
  • Makoto Kuroda
  • Michael Diamond
  • Seiya Yamayoshi
  • Tadashi Maemura

Best Publications

  • Molecular Basis for High Virulence of Hong Kong H5N1 Influenza A Viruses

    Masato Hatta;Peng Gao;Peter Halfmann;Yoshihiro Kawaoka;Yoshihiro Kawaoka

  • Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

    Unknown

  • Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

    Darwyn Kobasa;Steven M. Jones;Steven M. Jones;Kyoko Shinya;John C. Kash

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.

    Masaki Imai;Kiyoko Iwatsuki-Horimoto;Masato Hatta;Samantha Loeber

  • SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    Yixuan J. Hou;Shiho Chiba;Peter Halfmann;Camille Ehre

  • Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

    Darwyn Kobasa;Ayato Takada;Kyoko Shinya;Kyoko Shinya;Masato Hatta

  • Transmission of SARS-CoV-2 in Domestic Cats.

    Peter J. Halfmann;Masato Hatta;Shiho Chiba;Tadashi Maemura

  • Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner

    Asuka Nanbo;Masaki Imai;Shinji Watanabe;Takeshi Noda

  • Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

    Unknown

  • Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2

    Unknown

  • Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB

    Unknown

  • An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

    Unknown

  • Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters

    Unknown

  • Defining the risk of SARS-CoV-2 variants on immune protection

    Unknown

  • Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle

    Zachary A. Bornholdt;Takeshi Noda;Dafna M. Abelson;Peter Halfmann

  • Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains

    Unknown

  • Pathogenicity and transmissibility of bovine H5N1 influenza virus

    Unknown

  • A Role for Fc Function in Therapeutic Monoclonal Antibody-Mediated Protection against Ebola Virus.

    Bronwyn M. Gunn;Wen Han Yu;Marcus M. Karim;Jennifer M. Brannan

  • Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection

    Erica Ollmann Saphire;Sharon L. Schendel;Marnie L. Fusco;Karthik Gangavarapu

  • The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells

    Asuka Nanbo;Shinji Watanabe;Peter Halfmann;Yoshihiro Kawaoka

  • Generation of biologically contained Ebola viruses

    Peter Halfmann;Jin Hyun Kim;Hideki Ebihara;Takeshi Noda

  • The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses

    Eve Isabelle Pécheur;Viktoriya Borisevich;Peter Halfmann;John D. Morrey

  • Longitudinal Analysis of the Human B Cell Response to Ebola Virus Infection.

    Carl W. Davis;Katherine J.L. Jackson;Katherine J.L. Jackson;Anita K. McElroy;Anita K. McElroy;Anita K. McElroy;Peter Halfmann

  • Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus

    Andrew S. Taft;Makoto Ozawa;Adam Fitch;Jay V. Depasse

  • Ebola Virus (EBOV) VP24 Inhibits Transcription and Replication of the EBOV Genome

    Shinji Watanabe;Takeshi Noda;Peter Halfmann;Luke Jasenosky

  • A shared structural solution for neutralizing ebolaviruses

    João M Dias;Ana I Kuehne;Dafna M Abelson;Shridhar Bale

  • Characterization of a Human H5N1 Influenza A Virus Isolated in 2003

    Kyoko Shinya;Masato Hatta;Shinya Yamada;Ayato Takada

  • Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets.

    Haley L. Dugan;Christopher T. Stamper;Lei Li;Siriruk Changrob

  • The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Ebola virus Replication

    Lindsay Hill-Batorski;Peter Halfmann;Gabriele Neumann;Yoshihiro Kawaoka;Yoshihiro Kawaoka

Frequent Co-Authors

Yoshihiro Kawaoka
Yoshihiro Kawaoka University of Tokyo
Gabriele Neumann
Gabriele Neumann University of Wisconsin–Madison
Masato Hatta
Masato Hatta University of Wisconsin–Madison
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Takeshi Noda
Takeshi Noda Kyoto University
Heinz Feldmann
Heinz Feldmann National Institutes of Health
David H. O’Connor
David H. O’Connor University of Wisconsin–Madison
Florian Krammer
Florian Krammer Icahn School of Medicine at Mount Sinai
Shinji Watanabe
Shinji Watanabe National Institutes of Health
Andrzej Joachimiak
Andrzej Joachimiak Argonne National Laboratory

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of related online degrees and career paths in healthcare and life sciences. For students looking at alternative routes, it's encouraging to know that there are degrees felons can get, ensuring education opportunities remain accessible to many.

A popular healthcare role related to microbiology is the Functional Medicine Nurse Practitioner. To pursue this path, understanding how to become a functional medicine nurse practitioner is essential, as it combines advanced medical knowledge with patient-centered care.

For those interested in the administrative side, a career as a certified professional coder is a strong option. This role involves translating medical data into codes crucial for billing and documentation.

Additionally, a bachelor of science in health information management salary can be an attractive consideration, as it prepares graduates for managing health data—an essential function in medical research and patient care environments linked to microbiology.

Best Scientists Citing Peter Halfmann

Trending Scientists